vs
Side-by-side financial comparison of MID PENN BANCORP INC (MPB) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
MID PENN BANCORP INC is the larger business by last-quarter revenue ($62.0M vs $57.6M, roughly 1.1× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 30.8%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $-167.0M).
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
MPB vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.0M | $57.6M |
| Net Profit | $19.4M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | 43.6% | — |
| Net Margin | 31.4% | — |
| Revenue YoY | 30.8% | 94.1% |
| Net Profit YoY | 47.0% | 71.6% |
| EPS (diluted) | $0.83 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.0M | $57.6M | ||
| Q3 25 | $61.8M | $49.5M | ||
| Q2 25 | $54.3M | $39.5M | ||
| Q1 25 | $47.7M | $28.5M | ||
| Q4 24 | $47.4M | $29.7M | ||
| Q3 24 | $45.3M | $16.4M | ||
| Q2 24 | $44.1M | $7.3M | ||
| Q1 24 | $42.3M | — |
| Q4 25 | $19.4M | — | ||
| Q3 25 | $18.3M | $-30.0M | ||
| Q2 25 | $4.8M | $-75.8M | ||
| Q1 25 | $13.7M | $-94.3M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $12.3M | $-85.6M | ||
| Q2 24 | $11.8M | $-91.4M | ||
| Q1 24 | $12.1M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | 43.6% | — | ||
| Q3 25 | 39.3% | -30.8% | ||
| Q2 25 | 7.9% | -151.7% | ||
| Q1 25 | 35.2% | -276.5% | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 32.8% | -433.0% | ||
| Q2 24 | 32.4% | -1055.4% | ||
| Q1 24 | 34.8% | — |
| Q4 25 | 31.4% | — | ||
| Q3 25 | 29.6% | -60.5% | ||
| Q2 25 | 8.8% | -191.9% | ||
| Q1 25 | 28.8% | -330.7% | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 27.1% | -523.3% | ||
| Q2 24 | 26.7% | -1248.6% | ||
| Q1 24 | 28.7% | — |
| Q4 25 | $0.83 | — | ||
| Q3 25 | $0.79 | $-0.41 | ||
| Q2 25 | $0.22 | $-1.05 | ||
| Q1 25 | $0.71 | $-1.31 | ||
| Q4 24 | $0.72 | — | ||
| Q3 24 | $0.74 | $-1.32 | ||
| Q2 24 | $0.71 | $-1.56 | ||
| Q1 24 | $0.73 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $814.1M | $-438.2M |
| Total Assets | $6.1B | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $130.0M | ||
| Q3 25 | — | $135.2M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $212.3M | ||
| Q4 24 | — | $297.3M | ||
| Q3 24 | — | $334.7M | ||
| Q2 24 | — | $276.2M | ||
| Q1 24 | — | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | $814.1M | $-438.2M | ||
| Q3 25 | $796.3M | $-422.5M | ||
| Q2 25 | $775.7M | $-405.8M | ||
| Q1 25 | $667.9M | $-338.4M | ||
| Q4 24 | $655.0M | $-253.6M | ||
| Q3 24 | $573.1M | $-187.1M | ||
| Q2 24 | $559.7M | $-233.8M | ||
| Q1 24 | $551.0M | — |
| Q4 25 | $6.1B | $259.1M | ||
| Q3 25 | $6.3B | $240.3M | ||
| Q2 25 | $6.4B | $250.2M | ||
| Q1 25 | $5.5B | $294.2M | ||
| Q4 24 | $5.5B | $378.3M | ||
| Q3 24 | $5.5B | $387.0M | ||
| Q2 24 | $5.4B | $319.4M | ||
| Q1 24 | $5.3B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $-166.8M |
| Free Cash FlowOCF − Capex | $71.8M | $-167.0M |
| FCF MarginFCF / Revenue | 115.8% | -290.0% |
| Capex IntensityCapex / Revenue | 13.3% | 0.4% |
| Cash ConversionOCF / Net Profit | 4.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | $132.1M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | $-166.8M | ||
| Q3 25 | $26.3M | $-14.1M | ||
| Q2 25 | $29.0M | $-62.7M | ||
| Q1 25 | $11.5M | $-84.9M | ||
| Q4 24 | $51.4M | $-266.8M | ||
| Q3 24 | $16.9M | $-63.6M | ||
| Q2 24 | $18.0M | $-70.7M | ||
| Q1 24 | $12.4M | — |
| Q4 25 | $71.8M | $-167.0M | ||
| Q3 25 | $24.3M | $-14.1M | ||
| Q2 25 | $27.2M | $-62.8M | ||
| Q1 25 | $8.8M | $-84.9M | ||
| Q4 24 | $44.5M | $-266.9M | ||
| Q3 24 | $16.8M | $-63.6M | ||
| Q2 24 | $17.7M | $-70.8M | ||
| Q1 24 | $12.1M | — |
| Q4 25 | 115.8% | -290.0% | ||
| Q3 25 | 39.4% | -28.6% | ||
| Q2 25 | 50.1% | -159.0% | ||
| Q1 25 | 18.4% | -297.9% | ||
| Q4 24 | 93.8% | -899.8% | ||
| Q3 24 | 37.1% | -389.0% | ||
| Q2 24 | 40.2% | -966.2% | ||
| Q1 24 | 28.5% | — |
| Q4 25 | 13.3% | 0.4% | ||
| Q3 25 | 3.1% | 0.1% | ||
| Q2 25 | 3.2% | 0.2% | ||
| Q1 25 | 5.7% | 0.1% | ||
| Q4 24 | 14.6% | 0.5% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.7% | 0.6% | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 6.08× | — | ||
| Q1 25 | 0.84× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.02× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
